The pathogenesis of benign prostatic hyperplasia: A proposed hypothesis and critical evaluation

Journal of Urology

Volumn 160, Issue 6 II, 1998, Pages 2375-2380

  Grayhack, John T ^a   Kozlowski, James M ^a   Lee, Chung ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epididymis; Plasma; Prostatic hypertrophy; Testis

Indexed keywords

ANDROGEN; GROWTH PROMOTOR; MITOGENIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DOG; EPIDIDYMIS; EVALUATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SPERMATOCELE; SPERMATOGENESIS; STROMA CELL; TESTIS;

EID: 0032846545     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62195-5     Document Type: Article

References (54)

1. Lee, C., Kozlowski, J. M. and Grayhack, J. T.: Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate, 31: 131, 1997.
2. Sutkowski, D. M., Kasjanski, R. Z., Sensibar, J. A., Ney, K. G., Lim, D. J., Kozlowski, J. M., Lee, C. and Grayhack, J. T.: Effect of spermatocele fluid on growth of human prostatic cells in culture. J. Androl., 14: 233, 1993.
3. Grayhack, J. T., Sensibar, J. A., Ilio, K. Y., Kasjanski, R. Z., Kozlowski, J. M. and Lee, C.: Synergistic action of steroids and spermatocele fluid on in vitro proliferation of prostate stroma. J. Urol., 159: 2202, 1998.
4. Lewitton, M., Kim, E. D., Fallick, M. A., Lipshultz, L. I. and Grayhack, J. T.: Decreased total and transition zone prostatic volumes in men with congenital absence of the vas supports a prostate growth role of local exposure to testicular epididymal plasma. J. Urol., part 2, 159: 113, abstract 434, 1998.
5. Ilio, K., Lee, C. and Grayhack, J. T.: Dog testicular epididymal plasma requires androgen to stimulate prostate stroma in vitro. J. Urol., part 2, 157: 282, abstract 1095, 1997.
6. Ilio, K. Y., Grayhack, J. T. and Lee, C.: The effect of experimental cryptorchidism on the in vivo and in vitro growth of the rat ventral prostate. Biol. Reprod., submitted for publication, 1998.
7. Pierrepoint, C. G.: Does hormone transfer along the vasa deferentia contribute to the control of prostatic function and could it be a factor in the etiology of prostatic hyperplasia? In: Symposium in the Normal and Abnormal Growth of the Prostate. Edited by M. Goland. Springfield: Charles C. Thomas, chapt. 29, pp. 517-529, 1975.
8. Pierrepoint, C. G., Davies, P., Lewis, M. H. and Moffat, D. B.: Examination of the hypothesis that a direct control system exists for the prostate and seminal vesicles. J. Reprod. Fert., 44: 395, 1975.
9. White, J. W.: The results of double castration in hypertrophy of the prostate. Ann. Surg., 22: 1, 1895.
10. Mostofi, F. K. and Thompson, R. V.: Benign hyperplasia of the prostate gland. In: Urology, 2nd ed. Edited by M. F. Campbell. Philadelphia: W. B. Saunders, Co., vol. 2, chapt. 25, pp. 1101-1157, 1963.
11. Keyes, E. L. and Ferguson, A. B.: Urology, 6th ed. New York: D. Appleton-Century Co., Inc., p. 203, 1936.
12. Isaacs, J. T. and Coffey, D. S.: Etiology and disease process of benign prostatic hyperplasia. Prostate, suppl., 2: 33, 1989.
13. Coffey, D. S. and Walsh, P. C.: Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. N. Amer., 17: 461, 1990.
14. Lawson, R. K.: Etiology of benign prostatic hyperplasia. In: Prostate Diseases. Edited by H. Lepor and R. K. Lawson. Philadelphia: W. B. Saunders, Co., chapt. 7, pp. 89-95, 1993.
15. Grayhack, J. T., Lee, C. and Kozlowski, J. M.: Pathogenesis of benign prostatic hyperplasia. In: Alternate Methods in the Treatment of Benign Prostatic Hyperplasia. Edited by N. Romas and D. Vaughn. New York: Springer-Verlag, chapt. 2, pp. 13-25, 1993.
16. Lee, C., Kozlowski, J. M. and Grayhack, J. T.: Etiology of benign prostatic hyperplasia. Urol. Clin. N. Amer., 22: 237, 1995.
17. Nankin, H. R. and Calkin, J. H.: Decreased bioavailable testosterone in aging normal and impotent men. J. Clin. Endocr. Metab., 63: 1418, 1986.
18. Berry, S. J., Coffey, D. S. and Walsh, P. C.: The development of human benign prostatic hyperplasia with age. J. Urol., 132: 474, 1984.
19. Grayhack, J. T.: Changes with aging in human seminal vesicle fluid fructose concentration and seminal vesicle weight. J. Urol., 86: 142, 1961.
20. Grayhack, J. T. and Kropp, K. A.: Changes with aging in prostatic fluid: citric acid, acid phosphatase and lactic dehydrogenase concentration in man. J. Urol., 56: 6, 1965.
21. Grayhack, J. T., Lee, C. and Brand, W.: The effect of testicular irradiation in established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance. J. Urol., 134: 1276, 1985.
22. Juniewicz, P. E., Berry, S. J. and Coffey, D. S.: The requirement of testes in establishing the sensitivity of the canine prostate to develop benign prostatic hyperplasia. J. Urol., 152: 996, 1994.
23. Dalton, D. P., Lee, C., Huprikar, S., Chmiel, J. and Grayhack, J. T.: Nonandrogenic role of testis in enhancing ventral prostate growth in rats. Prostate, 16: 225, 1990.
24. Darras, F. S., Lee, C., Huprikar, S., Rademaker, A. W. and Grayhack, J. T.: Evidence for a nonandrogenic role of testis and epididymis in androgen-supported growth of the rat ventral prostate. J. Urol., 148: 432, 1992.
25. Cooke, P. S. and Meisami, E.: Early hypothyroidism in rats causes increased adult testis and reproductive organ size but does not change testosterone levels. Endocrinology, 129: 237, 1991.
26. Cooper, T. G., Raczek, S., Yeung, C. H., Schwab, E., Schulze, H. and Hertle, L.: Composition of fluids obtained from human epididymal cysts. Urol. Res., 20: 275, 1992.
27. Ewing, L. L.: Testis: changes with age. In: Benign Prostatic Hyperplasia. Edited by J. T. Grayhack, J. D. Wilson and M. J. Scherbenske, Washington, D. C.: U.S. Government Printing Office, pp. 195-204, 1975.
28. Lynch, K. M., Jr. and Scott, W. W.: The lipid content of the Leydig cell and Sertoli cell in human testis as related to age, benign prostatic hyperplasia and prostatic cancer. J. Urol., 64: 767, 1950.
29. Johnson, L.: Spermatogenesis and aging. J. Androl., 7: 331, 1986.
30. Moore, R. A.: Benign hypertrophy of the prostate: occurrence and experimental production in animals. Surgery, 16: 152, 1944.
31. Franks, L. M.: Benign nodular hyperplasia of the prostate: a review. Ann. Roy. Col. Surg. (Engl.), 14: 92, 1954.
32. McNeal, J. E.: Origin and evolution of benign prostatic enlargement. Invest. Urol., 15: 340, 1978.
33. Bierhoff, E., Vogel, J., Benz, M., Giefer, T., Wernert, N. and Pfeifer, U.: Stromal nodules in benign prostatic hyperplasia. Eur. Urol., 29: 345, 1996.
34. McNeal, J.: Pathology of benign prostatic hyperplasia: insight into etiology. Urol. Clin. N. Amer., 17: 447, 1990.
35. Moore, R. A.: Benign hypertrophy of the prostate: a morphological study. J. Urol., 50: 680, 1943.
36. Symmers, W. St. T. C.: The Breasts in Systemic Pathology, 2nd ed. New York: Churchill Livingston, vol. 4, chapt. 28, pp. 1760-1861, 1978.
37. Volsi, L.: Pathology of thyroid disease. In: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiotherapy, 2nd ed. Edited by S. A. Falk. Philadelphia: Lippincott Raven Publishers, pp. 65-104, 1997.
38. McNicol, A. M. and Lardlen, P.: The thyroid gland. In: Systemic Pathology, 3rd ed. Edited by W. St. C. Symmers. New York: Churchill Livingstone, vol. 12, chapt. 5, pp. 131-185, 1996.
39. McNicol, A. M. and Lardlen, P.: The adrenal gland and extra-adrenal paraganglia. In: Systemic Pathology, 3rd ed. Edited by W. St. C. Symmers. New York: Churchill Livingstone, vol. 12, chapt. 4, pp. 59-129, 1996.
40. Grayhack, J. T. and Kozlowski, J. M.: Benign prostatic hyperplasia. In: Adult and Pediatric Urology, 3rd ed. Edited by J. Gillenwater, J. Grayhack, S. Howards and J. M. Duckett. St. Louis: Mosby, vol. 2, chapt. 31, pp. 1501-1574, 1996.
41. Partin, A. W., Page, W. F., Lee, B. R., Sanda, M. G., Miller, R. N. and Walsh, P. C.: Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology, 44: 646, 1994.
42. Sanda, M. G., Beaty, T. H. and Stutzman, R. E.: Genetic susceptibility of benign prostatic hyperplasia. J. Urol., 152: 115, 1994.
43. Eldrup, J., Thorup, J., Nielsen, S. L., Hald, T. and Hainau, B.: Permeability and ultrastructure of human bladder epithelium. Brit. J. Urol., 55: 488, 1983.
44. 99mtechnetium-diethylenetriaminepentaacetic acid. J. Urol., 151: 346, 1994.
45. Hudson, M'Liss A. and Catalona, W. J.: Urothelial tumors of the bladder, upper tracts, and prostate. In: Adult and Pediatric Urology, 3rd ed. Edited by J. Gillenwater, J. Grayhack, S. Howards and J. M. Duckett. St. Louis: Mosby, vol. 2, chapt. 29, pp. 1379-1464, 1996.
46. Grayhack, J. T.: The effect of local testosterone administration on the prostate of the rat. Endocrinology, 63: 399, 1958.
47. Howards, S. S.: Possible biological mechanisms for a relationship between vasectomy and prostate cancer. Eur. J. Cancer, suppl., 29A: 1060, 1993.
48. Meacham, R. B., Lipschultz, L. I. and Howards, S. S.: Male infertility: vasal agenesis. In: Adult and Pediatric Urology, 3rd ed. Edited by J. Gillenwater, J. Grayhack, S. Howards and J. Duckett. St. Louis: Mosby, chapt. 34, pp. 1738-1784, 1996.
49. Jakobsen, H., Torp-Pedersen, S., Juul, N. and Hald, T.: The long-term influence of vasectomy on prostatic volume and morphology in man. Prostate, 13: 57, 1988.
50. Naik, V. K., Joshi, U. M. and Sheth, A. R.: Long-term effects of vasectomy on prostatic function in men. J. Reprod. Fert., 58: 289, 1980.
51. Jakobsen, H., Rui, H., Thomassen, Y., Hald, T. and Purvis, K.: Polyamines and other accessory sex gland secretions in human seminal plasma 8 years after vasectomy. J. Reprod. Fertil., 87: 39, 1989.
52. Sidney, S.: Vasectomy and the risk of prostatic cancer and benign prostatic hypertrophy. J. Urol., 138: 795, 1987.
53. Wilson, J. D., Gloyna, R. E. and Siiteri, P. K.: Androgen metabolism in the hypertrophic prostate. J. Steroid Biochem., 6: 443, 1975.
54. Partin, A. W., Oesterling, J. E., Epstein, J. I., Horton, R. and Walsh, P. C.: Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J. Urol., 145: 405, 1991.